Alan R. Rendina

3.5k total citations
55 papers, 1.7k citations indexed

About

Alan R. Rendina is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Alan R. Rendina has authored 55 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 20 papers in Hematology and 16 papers in Genetics. Recurrent topics in Alan R. Rendina's work include Blood Coagulation and Thrombosis Mechanisms (20 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers) and Hemophilia Treatment and Research (11 papers). Alan R. Rendina is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (20 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers) and Hemophilia Treatment and Research (11 papers). Alan R. Rendina collaborates with scholars based in United States, Germany and Sweden. Alan R. Rendina's co-authors include Joseph M. Luettgen, Ruth R. Wexler, Robert M. Knabb, Pancras C. Wong, Kan He, Patrick Y. S. Lam, Donald Pinto, Angela Smallwood, Dong Cheng and Karen A. Rossi and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Alan R. Rendina

54 papers receiving 1.7k citations

Peers

Countries citing papers authored by Alan R. Rendina

Since Specialization

Citations

This map shows the geographic impact of Alan R. Rendina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan R. Rendina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan R. Rendina more than expected).

Fields of papers citing papers by Alan R. Rendina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan R. Rendina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan R. Rendina. The network helps show where Alan R. Rendina may publish in the future.

Co-authorship network of co-authors of Alan R. Rendina

This figure shows the co-authorship network connecting the top 25 collaborators of Alan R. Rendina. A scholar is included among the top collaborators of Alan R. Rendina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan R. Rendina. Alan R. Rendina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Expedited SARS‐CoV‐2 Main Protease Inhibitor Discovery through Modular ‘Direct‐to‐Biology’ Screening 2024 ·Angewandte Chemie ·(unknown), (unknown), Sam M. Rowe, (unknown), (unknown), Alan R. Rendina, Emma K. Grant, Jonathan Pettinger, David J. Fallon, Mark Skehel, David House, Nicholas C. O. Tomkinson, Jacob T. Bush	1
2	Expedited SARS‐CoV‐2 Main Protease Inhibitor Discovery through Modular ‘Direct‐to‐Biology’ Screening 2024 ·Angewandte Chemie International Edition ·(unknown), (unknown), Sam M. Rowe, (unknown), (unknown), Alan R. Rendina, Emma K. Grant, Jonathan Pettinger, David J. Fallon, Mark Skehel, David House, Nicholas C. O. Tomkinson, Jacob T. Bush	6
3	A highly selective, cell-permeable furin inhibitor BOS-318 rescues key features of cystic fibrosis airway disease 2022 ·Cell chemical biology ·(unknown), James Reihill, Melisa W-Y. Ho, Jeffrey M. Axten, Nino Campobasso, Jessica L. Schneck, Alan R. Rendina, Keith Wilcoxen, Lorraine Martin	18
4	Mechanistic MALDI-TOF Cell-Based Assay for the Discovery of Potent and Specific Fatty Acid Synthase Inhibitors 2019 ·Cell chemical biology ·(unknown), Cynthia A. Parrish, Julie A. Krueger, Catherine A. Oleykowski, Alan R. Rendina, Carsten Hopf	13
5	Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime group 2016 ·Bioorganic & Medicinal Chemistry ·James R. Corte, Tianan Fang, Donald Pinto, Michael J. Orwat, Alan R. Rendina, Joseph M. Luettgen, Karen A. Rossi, Anzhi Wei, Vidhyashankar Ramamurthy, Joseph E. Myers, S. Sheriff, Rangaraj Narayanan, Timothy W. Harper, Joanna J. Zheng, Yixin Li, Dietmar Seiffert, Ruth R. Wexler, Mimi L. Quan	15
6	Structure-based design of inhibitors of coagulation factor XIa with novel P1 moieties 2015 ·Bioorganic & Medicinal Chemistry Letters ·Donald Pinto, Joanne M. Smallheer, James R. Corte, (unknown), (unknown), Tianan Fang, Leon M. Smith, Karen A. Rossi, Alan R. Rendina, Jeffrey M. Bozarth, Ge Zhang, Anzhi Wei, Vidhyashankar Ramamurthy, S. Sheriff, Joseph E. Myers, Paul E. Morin, Joseph M. Luettgen, Dietmar Seiffert, Mimi L. Quan, Ruth R. Wexler	26
7	Orally bioavailable factor Xa inhibitors containing alpha-substituted gem-dimethyl P4 moieties 2014 ·Bioorganic & Medicinal Chemistry Letters ·Michael J. Orwat, Jennifer X. Qiao, Kan He, Alan R. Rendina, Joseph M. Luettgen, Karen A. Rossi, Baomin Xin, Robert M. Knabb, Ruth R. Wexler, Patrick Y. S. Lam, Donald Pinto	7
8	Pyridine and pyridinone-based factor XIa inhibitors 2014 ·Bioorganic & Medicinal Chemistry Letters ·James R. Corte, Tianan Fang, Jon J. Hangeland, (unknown), Alan R. Rendina, Joseph M. Luettgen, Jeffrey M. Bozarth, Frank Barbera, Karen A. Rossi, Anzhi Wei, Vidhyashankar Ramamurthy, Paul E. Morin, Dietmar Seiffert, Ruth R. Wexler, Mimi L. Quan	14
9	A human fatty acid synthase inhibitor binds β-ketoacyl reductase in the keto-substrate site 2014 ·Nature Chemical Biology ·Mary Ann Hardwicke, Alan R. Rendina, Shawn P. Williams, Michael L. Moore, Liping Wang, Julie A. Krueger, Ramona Plant, Rachel D. Totoritis, Guofeng Zhang, Jacques Briand, William Burkhart, Kristin K. Brown, Cynthia A. Parrish	87
10	Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF–FVIIa inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Xiaojun Zhang, Peter W. Glunz, Wen Jiang, (unknown), (unknown), Frank Barbera, (unknown), Alan R. Rendina, Anzhi Wei, (unknown), Karen A. Rossi, Joseph M. Luettgen, Pancras C. Wong, Robert M. Knabb, Ruth R. Wexler, E. Scott Priestley	7
11	Nonbenzamidine acylsulfonamide tissue factor–factor VIIa inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Peter W. Glunz, Xiaojun Zhang, Yan Zou, (unknown), (unknown), Xuhong Cheng, Carolyn A. Weigelt, Daniel L. Cheney, Anzhi Wei, (unknown), Joseph M. Luettgen, Alan R. Rendina, Mark R. Harpel, Gang Luo, Robert M. Knabb, Pancras C. Wong, Ruth R. Wexler, E. Scott Priestley	13
12	Differential activation of recombinant human acetyl-CoA carboxylases 1 and 2 by citrate 2008 ·Archives of Biochemistry and Biophysics ·Gregory Locke, Dong Cheng, Mark R. Witmer, James Tamura, Tasir S. Haque, (unknown), Alan R. Rendina, Jovita Marcinkeviciene	16
13	Structure–activity relationships of anthranilamide-based factor Xa inhibitors containing piperidinone and pyridinone P4 moieties 2008 ·Bioorganic & Medicinal Chemistry Letters ·James R. Corte, Tianan Fang, Donald Pinto, Wei Han, Zilun Hu, (unknown), Yunlong Li, (unknown), Mark Hadden, (unknown), Alan R. Rendina, Joseph M. Luettgen, Pancras C. Wong, Kan He, Paul E. Morin, Chong‐Hwan Chang, Daniel L. Cheney, Robert M. Knabb, Ruth R. Wexler, Patrick Y. S. Lam	27
14	Achieving structural diversity using the perpendicular conformation of alpha-substituted phenylcyclopropanes to mimic the bioactive conformation of ortho-substituted biphenyl P4 moieties: Discovery of novel, highly potent inhibitors of Factor Xa 2008 ·Bioorganic & Medicinal Chemistry Letters ·Jennifer X. Qiao, Daniel L. Cheney, Richard Alexander, Angela Smallwood, (unknown), Kan He, Alan R. Rendina, Joseph M. Luettgen, Robert M. Knabb, Ruth R. Wexler, Patrick Y. S. Lam	49
15	SAR and X-ray structures of enantiopure 1,2-cis-(1R,2S)-cyclopentyldiamine and cyclohexyldiamine derivatives as inhibitors of coagulation Factor Xa 2007 ·Bioorganic & Medicinal Chemistry Letters ·Jennifer X. Qiao, Chong‐Hwan Chang, Daniel L. Cheney, Paul E. Morin, (unknown), (unknown), Tammy C. Wang, Alan R. Rendina, Joseph M. Luettgen, Robert M. Knabb, Ruth R. Wexler, Patrick Y. S. Lam	29
16	Enantiopure five-membered cyclicdiamine derivatives as potent and selective inhibitors of factor Xa. Improving in vitro metabolic stability via core modifications 2007 ·Bioorganic & Medicinal Chemistry Letters ·Jennifer X. Qiao, Tammy C. Wang, (unknown), Daniel L. Cheney, Kan He, Alan R. Rendina, Baomin Xin, Joseph M. Luettgen, Robert M. Knabb, Ruth R. Wexler, Patrick Y. S. Lam	17
17	Abstract 631: Nonpeptide Factor XIa (FXIa) Inhibitor. In vitro Kinetic Evaluation and in vivo Studies of BMS-262084 on Arterial Thrombosis and Hemostasis in Rabbits 2006 ·Circulation ·Pancras C. Wong, William A. Schumacher, Carol A. Watson, Earl J. Crain, Martin L. Ogletree, Alan R. Rendina	3
18	Dethiobiotin Synthetase: The Carbonylation of 7,8-Diaminononanoic Acid Proceeds Regiospecifically via the N7-Carbamate 1995 ·Biochemistry ·Katharine J. Gibson, George H. Lorimer, Alan R. Rendina, (unknown), Gary H. Cohen, A.A. Gatenby, (unknown), D. Christopher Roe, (unknown)	30
19	Mechanism of an ATP-Dependent Carboxylase, Dethiobiotin Synthetase, Based on Crystallographic Studies of Complexes with Substrates and a Reaction Intermediate 1995 ·Biochemistry ·Weijun Huang, Jia Jia, Katharine J. Gibson, (unknown), Alan R. Rendina, G. Schneider, Ylva Lindqvist	56
20	Kinetic characterization, stereoselectivity, and species selectivity of the inhibition of plant acetyl-CoA carboxylase by the aryloxyphenoxypropionic acid grass herbicides 1988 ·Archives of Biochemistry and Biophysics ·Alan R. Rendina, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact